Kiribati regulates prescription supply of cannabis extracts and tinctures

Kiribati’s 1980 Dangerous Drugs Regulations expressly contemplate a narrow pharmaceutical use of cannabis. Regulation 9 authorises registered pharmacists in business to manufacture extracts or tinctures of Indian hemp at their shop in the ordinary course of retail business. That wording is more specific than a general power to license controlled drugs.

The regulations commenced on 21 February 1980. They were made under section 15 of the Dangerous Drugs Ordinance and apply to Part IV drugs and preparations. Schedule 2 Part I paragraph 7 of the ordinance includes cannabis extracts and tinctures.

A prescription system

Regulation 6 prohibits unauthorised possession, but recognises possession following lawful prescription supply. It also addresses the situation in which a patient receives drugs from more than one practitioner without disclosing the other treatment.

Regulations 11 and 12 define the required prescription and impose duties on the supplier. The dispenser must check the prescription’s form and authenticity, mark the dispensing date and retain it for inspection. Regulation 9 requires controlled drugs in a pharmacist’s custody to be kept in a locked receptacle, accessible only to the pharmacist or a registered pharmacist assistant. Regulations 14 and 15 require transaction records and preservation of documents.

These provisions establish legal controls on preparation and supply. They do not establish which cannabis medicines were actually compounded, whether they are stocked today, how many patients received them or whether a particular foreign prescription would be accepted.

Preparations and plants are treated separately

The pharmaceutical provisions must be read alongside the plant prohibitions. Sections 7 and 8 of the ordinance prohibit cannabis cultivation, including for private use. Section 8 also covers possession, giving and selling Indian hemp. The statutory authority to prepare an extract or tincture is therefore not a general permission to grow plants or sell cannabis flower.

This distinction supports a limited medical-framework label in the database. It does not justify increasing the legal-access score without evidence that a patient route operates in practice. The profile keeps that availability gap explicit.

The older ordinance is documented in the 1948 history entry. Its 1977 revised edition and these later regulations are separate sources; neither should be presented as a complete consolidation of every subsequent amendment.^[1][2]